AI for Drug Discovery and Development Market

Artificial intelligence has significant applications in the drug discovery field as it helps track diseases, create disease cures and predict which animal viruses appear to mutate. Artificial intelligence has been known to enhance R&D in drug discovery, which has helped researchers to discover chronic disease treatments. Drug discovery and development in the fields of medicine, pharmacology, and biotechnology are processes for the creation, design, and procurement of a drug through identifying a biological target, such as enzyme protein, gene, or receptor. Previously, the drugs were discovered by identifying the active ingredient conventional treatments. Thus, drug discovery is the first step in the process of identifying potential novel drugs and their medicinal purpose. New criteria for drugs are measured based on their bioavailability, efficacy, potency, and toxicity.
AI for Drug Discovery and Development Market contains market size and forecasts of AI for Drug Discovery and Development in Global, including the following market information:
Global AI for Drug Discovery and Development Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global AI for Drug Discovery and Development market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Target Identification Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of AI for Drug Discovery and Development include Alphabet, Atomwise, BenevolentAI, Cloud Pharmaceutical, Deep Genomics, Exscientia, IBM, Insilico Medicine and Microsoft Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the AI for Drug Discovery and Development companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AI for Drug Discovery and Development Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global AI for Drug Discovery and Development Market Segment Percentages, by Type, 2021 (%)
Target Identification
Molecule Screening
De Novo Drug Design and Drug Optimization
Preclinical and Clinical Testing
Others
Global AI for Drug Discovery and Development Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global AI for Drug Discovery and Development Market Segment Percentages, by Application, 2021 (%)
Oncology
Infectious Disease
Neurology
Others
Global AI for Drug Discovery and Development Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global AI for Drug Discovery and Development Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AI for Drug Discovery and Development revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies AI for Drug Discovery and Development revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alphabet
Atomwise
BenevolentAI
Cloud Pharmaceutical
Deep Genomics
Exscientia
IBM
Insilico Medicine
Microsoft Corporation
Nvidia Corporation
XtalPi
DP Technology
Tencent iDrug
PaddleHelix
EIHealth
Aliyun